High recurrence of the R1006C NOTCH3 mutation in central Italian patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

Neuroscience Letters

Volumn 462, Issue 2, 2009, Pages 176-178

  Cappelli, Alessia ^a,b   Ragno, Michele ^c   Cacchiò, Gabriella ^c   Scarcella, Maria ^c   Staffolani, Paolo ^a   Pianese, Luigi ^a  

^a UO Laboratorio Analisi Cliniche e Microbiologiche   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c UO Neurologia   (Italy)

Author keywords

CADASIL; Leukoencephalopathy; Mutation; NOTCH3

Indexed keywords

NOTCH3 RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CADASIL; CONTROLLED STUDY; DNA SEQUENCE; EXON; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HETEROZYGOTE; HOMOZYGOTE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MUTATION RATE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS;

CADASIL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MALE; MUTATION; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, NOTCH;

EID: 67650960613     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.06.087     Document Type: Article

References (21)

1. Chabriat H., Vahedi K., Iba-Zizen M.T., Joutel A., Nibbio A., Nagy T.G., Krebs M.O., Julien J., Dubois B., Ducrocq X., Levasseur M., Homeyer P., Mas J.L., Lyon-Caen O., Tournier Lasserve E., and Bousser M.G. Clinical spectrum of CADASIL: a study of 7 families. Lancet 346 (1995) 934-939
2. Dichgans M. Cerebral autosomal dominant arteriopathy with subcortical infarcts: phenotype and mutation spectrum. J. Neurol. Sci. 203-204 (2002) 77-80
3. Dichgans M., Filippi M., Bruning R., Iannucci G., Berchtenbreiter C., Minicucci L., Uttner I., Crispin A., Ludwig H., Gasser T., and Yousry T.A. Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology 52 (1999) 1361-1367
4. Dichgans M., Herzog J., and Gasser T. NOTCH3 mutation involving three cysteine residues in a family with typical CADASIL. Neurology 57 (2001) 1714-1717
5. Dichgans M., Mayer M., Uttner I., Bruning R., Muller-Hocker J., Rungger G., Ebke M., Klockgether T., and Gasser T. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann. Neurol. 44 (1998) 731-739
6. Dotti M.T., Federico A., Mazzei R., Bianchi S., Scali O., Conforti F.L., Sprovieri T., Guidetti D., Aguglia U., Consoli D., Pantoni L., Sarti C., Inzitari D., and Quattrone A. The spectrum of Notch3 mutations in 28 Italian CADASIL families. J. Neurol. Neurosurg. Psychiatry 76 (2005) 736-738
7. Fouillade C., Chabriat H., Riant F., Mine M., Arnoud M., Magy L., Bousser M.G., Tournier-Lasserve E., and Joutel A. Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain. Hum. Mutat. 29 (2008) 452
8. Grigg R., Lea R., Sullivan A.A., Curtain R., MacMillian J., and Griffiths L. Identification of a novel mutation C144F in the Notch3 gene in an Australian CADASIL pedigree. Hum. Mutat. 16 (2000) 449-450
9. Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P., Alamowitch S., Domenga V., Cécillion M., Marechal E., Maciazek J., Vayssiere C., Cruaud C., Cabanis E.A., Ruchoux M.M., Weissenbach J., Bach J.F., Bousser M.G., and Tournier-Lasserve E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383 (1996) 707-710
10. Joutel A., Vahedi K., Corpechot C., Troesch A., Chabriat H., Vayssière C., Cruaud C., Maciazek J., Weissenbach J., Bousser M.G., Bach J.F., and Tournier-Lasserve E. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 350 (1997) 1511-1515
11. Jung H.H., Rosler K.M., Burgunder J.M., and Bassetti C. Peripheral nerve and muscle vessel lesions in CADASIL. Schweiz. Arch. Neurol. Psychiatr. 147 (1996) 148-150
12. Lesnik Oberstein S.A.J. Diagnostic strategy in CADASIL. Neurology 60 (2003) 2019-2020
13. Markus H.S., Martin R.J., Simpson M.A., Dong Y.B., Ali N., Crosby A.H., and Powell J.F. Diagnostic strategies in CADASIL. Neurology 59 (2002) 1134-1138
14. Mykkanen K., Savontaus M.L., Juvonen V., Sistonen P., Tuisku S., Tuominen S., Penttinen M., Lundkvist J., Viitanen M., Kalimo H., and Poyhonen M. Detection of the founder effect in Finnish CADASIL families. Eur. J. Hum. Genet. 12 (2004) 813-819
15. Opherk C., Peters N., Holtmannspoetter M., Gschwendtner A., Muller-Myhsok B., and Dichgans M. Heritability of MRI lesion volume in CADASIL: evidence for genetic modifiers. Stroke 37 (2006) 2684-2689
16. Ragno M., Fabrizi G.M., Cacchio G., Scarcella M., Sirocchi G., Selvaggio F., Taioli F., Ferrarini M., and Trojano L. Two novel Italian CADASIL families from Central Italy with mutation CGC-TGC at codon 1006 in the exon 19 Notch3 gene. Neurol. Sci. 27 (2006) 252-256
17. Ragno M., Tournier-Lasserve E., Fiori M.G., Manca A., Patrosso M.C., Ferlini A., Sirocchi G., Trojano L., Chabriat H., and Salvi F. An Italian kindred with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Ann. Neurol. 38 (1995) 231-236
18. Ruchoux M.M., Chabriat H., Bousser M.G., Baudrimont M., and Tournier-Lasserve E. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke 25 (1994) 2291-2292
19. Singhal S., Bevan S., Barrick T., Rich P., and Markus H.S. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 127 (2004) 2031-2038
20. Tikka S., Mykkänen K., Ruchoux M.M., Bergholm R., Junna M., Poyhonen M., Yki-Jarvinen H., Joutel A., Viitanen M., Baumann M., and Kalimo H. Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. Brain (2009) 10.1093/brain/awn364
21. Weinmaster G. The ins and outs of notch signalling. Mol. Cell. Neurosci. 9 (1997) 91-102